Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000954515 | SCV001101151 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000954515 | SCV002008109 | likely benign | not provided | 2020-10-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489322 | SCV002797935 | likely benign | Wooly hair-palmoplantar keratoderma syndrome; Nephrotic syndrome 16 | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000954515 | SCV005209409 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000954515 | SCV001741787 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000954515 | SCV001931441 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003926007 | SCV004741788 | likely benign | KANK2-related disorder | 2019-09-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |